August 2015 e17 CliniCAl PhArmACOlOgy EduCAtiOn in EurOPE: A timE tO ACt J.S. Penataro; J. Fernandez; L. Walker; B. Aydin; J. Holm; E.C.T. Geijteman; M. Roustit; S. Chhun; J. Versmissen; and M. Ezzeldin Clinical Pharmacology Department, Hospital Clinic, Barcelona, Spain; Clinical Pharmacology Department, Hospital Puerta de Hierro, Madrid, Spain; Liverpool University, Clinical Pharmacology Department, Liverpool, United Kingdom; Dokuz Eylul University, Faculty of Medicine, Medical Pharmacology Department, Izmir, Turkey; Karolinska University Hospital, Department of Clinical Pharmacology, Stockholm, Sweden; Erasmus University Medical Center, Department of Hospital Pharmacy, Rotterdam, The Netherlands; Centre d’Investigation Clinique, CHU de Grenoble, Pharmacologie Clinique,Universite Joseph Fourier. Grenoble, France; and Hopital Universitaire Necker-Enfants Malades, Faculte de Medecine Paris Descartes, Service d’Immunologie Biologique Background: Core competencies in clinical pharmacology (CP) education are well established but poorly harmonized within European national training programs, thus limiting cross-border career opportunities for young postgraduates. Opportunities for career development in CP differ to some extent in different countries in Europe, and much could be gained from international exchange of experiences and collaboration of clinical pharmacology trainees (CPT). Material and Methods: A European Task Force, with CPT representatives from Spain, Netherlands, UK, Sweden, France, and Turkey, has been created to identify and address the main deficits of and priorities in CP education across Europe. Two courses of action have been delineated: